세계의 바이오인포매틱스 서비스 시장 : 유형별, 용도별, 전문 분야별, 최종사용자별, 지역별, 기회 및 예측(2018-2032년)

Global bioinformatics services market is projected to witness a CAGR of 15.39% during the forecast period 2025-2032, growing from USD 3.44 billion in 2024 to USD 10.82 billion in 2032. The market's growth is augmented by the rising requirement for bioinformatics across a wide range of industries, increasing requirement for proteomics and genomics, growing public and private funding, and rising development of user-friendly bioinformatics software and tools that are increasing the efficiency and accessibility of bioinformatics services. The growing focus on precision healthcare and medicine is also augmenting the demand for various bioinformatics solutions and services to allow the discovery of various risk factors for different diseases, personalize therapeutic approaches on the basis of individual genetic data, and personalize therapeutic approaches. The advent of advanced technologies such as mass spectrometry and next-generation sequencing has resulted in an exponential increase in the volume of biological data that is being generated, thus bolstering the requirement for sophisticated services for storage, analysis, and interpretation of data.

Additionally, increasing focus on technological innovation and introduction of new bioinformatics tools that facilitate effective and accurate analysis of different tasks is also propelling the growth of the bioinformatics services market. For instance, in May 2024, Seqera, one of the leading software providers for complex data analysis for the life science industry, launched Seqera Containers, a streamlined bioinformatics container solution to create simplified experience and aid researchers and developers in effortlessly assembling different containers that are tailored to their requirements without uploading and building custom container images. With the help of this solution, the company is able to create a centralized hub for the different analytical requirements of scientists and support them by providing access to the scientific community to accelerate the pace of research processes.

The growing burden on pharmaceutical and biotechnology industries due to the rising prevalence of chronic diseases is augmenting the reliance on bioinformatics services to foster research activities, increase the development of novel drugs, diagnostic solutions, and support the development of precision medicine. Moreover, the rising efforts to increase the integration of machine learning and artificial intelligence with different bioinformatics tools are also augmenting the market's demand as this integration enhances data analysis and improves its accuracy, resulting in the development of new drugs in a time efficient manner. Rising investments in research and development along with increasing government initiatives that support cloud-based bioinformatics solutions and genomics research are other major factors fueling the market's expansion.

Innovation and Launch of New Services Support Market Expansion

Leading biotechnology services providing companies are increasingly investing in providing novel services and technologies including whole genome sequencing services for clinical and academic applications as well as for biotechnology and pharmaceutical companies. The rapid accumulation of vast amounts of biological data is propelling the requirement for advanced bioinformatics services for analyzing and interpreting complex biological data for creating new medications and tailored medical solutions. Thus, various bioinformatics companies are increasingly focusing on providing new technologies and services to their clients. For instance, in August 2024, Inocras Inc., started offering whole genome sequencing services with the help of the UG 100 sequencer, provided by Ultima Genomics, Inc. This collaborative effort of the two companies is expected to bolster the availability of affordable genomic solutions, facilitating wider adoption of bioinformatics and providing lucrative growth opportunities for the market.

Increasing Focus on Bioinformatics by Research Institutions Boosts Market Demand

The growing emphasis on bioinformatics research due to the rising requirement for the technique across a wide range of fields is propelling the demand for bioinformatics services. Various research and academic institutions are increasingly focused on launching bioinformatics centers to provide personalized medicines for a wide range of chronic diseases, further augmenting the growth of the global bioinformatics services market. For instance, in June 2024, the Washington University School of Medicine in St. Louis, Missouri, United States, formed a Center for Translational Bioinformatics to accelerate translational research that improves patient care by integrating expansive genomic and patient data. The center combines clinical data analysis with genomic research and supports the creation of technology platforms that bridge the gap between genetic, clinical, and research datasets. Such efforts of leading research institutions to augment bioinformatics science are expected to attract new investments and foster innovation, propelling the market's expansion and providing lucrative growth opportunities.

Drug Discovery Services Hold Significant Share of the Market

The dominance of drug discovery services can be attributed to the essential nature of bioinformatics tools and services for streamlining and accelerating the drug development process. Bioinformatics services aid drug developers in identifying potential drug targets, predicting drug interactions, and understanding complex disease mechanisms. Additionally, the rising requirement for precision medicines from various regions across the globe, along with increasing complexities of drug development processes, are also driving the requirement for bioinformatics services in drug discovery processes.

In order to ensure the availability of bioinformatics solutions for drug discovery applications, leading biotechnology companies across the globe are increasingly investing investments in providing customized solutions for the biopharmaceutical industry. For instance, in June 2024, Cyrus Biotechnology, Inc., a software-enabled biotechnology company, spun out a software and services group, Levitate Bio LLC, to bring Cyrus to the pharmaceutical sector. By providing a full stack of services and software, Levitate addresses the evolving requirements of the pharmaceutical industry, allowing the discovery of new drugs and expanding the capabilities of bioinformatics services in the pharmaceutical sector.

North America Region Holds Major Market Share

The market's rapid expansion in North America can be attributed to the strong presence of various companies focusing on proteomics and genomic technologies, the availability of enhanced infrastructure for life science and biotechnology research, and continuous investments in research and development activities. Additionally, the increasing efforts of educational institutions to introduce bioinformatics and artificial intelligence in the curriculum and prepare the students for the workforce by providing them with hands-on training are also driving innovations across the industry. For instance, in September 2024, Conectado Inc., one of the leading providers of immersive educational services, partnered with Hollister High School in California, United States, to provide specialized bootcamps in bioinformatics and artificial intelligence for the students. The bootcamps feature hands-on training on practical applications of bioinformatics and artificial intelligence and provide students with information about future career options in bioinformatics. Such efforts are bolstering awareness about the potential career opportunities in the bioinformatics sector and are expected to provide lucrative growth opportunities for the bioinformatics services market.

Future Market Scenario (2025 - 2032F)

As per the global bioinformatics services market analysis, the market is anticipated to witness lucrative growth opportunities over the coming years due to the increasing applications of bioinformatics in multiple industries, rising investments towards research and development activities, and technological advancements and innovations. The growing reliance on efficient data management and analysis tools coupled with the increasing focus on precision medicine are also expected to augment the reliance on bioinformatics services.

Cloud-based bioinformatics services are expected to gain traction in the coming years due to various advantages associated with these services including easy scalability and collaborative research, economic-efficiency, and increasing investments in cloud-based tools and services.

Additionally, increasing investments in the biotechnology industry due to the increasing applications of the technology across a broad range of fields coupled with rising collaborations and partnerships among leading research institutions and biotech companies to enhance bioinformatics solutions and services are also expected to foster innovation, positively influencing the market's expansion.

Key Players Landscape and Outlook

The key players in the market are actively engaging in mergers and acquisitions and partnerships to expand their global presence and provide end-to-end bioinformatics services. For instance, in November 2024, Solis Agrosciences Inc. acquired genomics platform of Ferris Genomics Inc., allowing Solis to provide end-to-end genomic services to agricultural customers. This acquisition is expected to allow Solis to expand its customer base and identify Ferris's technologies for identifying targets for leveraging genome and plant editing platforms to create new traits. Such acquisitions aim to create synergistic opportunities, providing lucrative growth opportunities for the market by offering integrated solutions to meet the evolving requirements of the plant biotechnology sector.

Similarly in April 2024, Strand Life Sciences Private Limited (a Reliance Industries Limited Subsidiary) partnered with SOPHiA GENETICS SA to deliver advanced solutions for augmenting the utilization of precision medicine across the globe. This partnership is focusing on strategic test development, among other initiatives for improving healthcare outcomes in different regions across the globe, including India. By combining their expertise, the companies are strengthening their position in the market. Such partnerships are bolstering the availability of tools and technologies that aid in accurate analysis of data, thus, positively influencing the expansion of the market.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Bioinformatics Services Market Outlook, 2018-2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Type
    • 4.2.1.1. Sequencing Services
      • 4.2.1.1.1. Exome Analysis
      • 4.2.1.1.2. Transcriptome Analysis
      • 4.2.1.1.3. Metagenomic Analysis
      • 4.2.1.1.4. Other Services
    • 4.2.1.2. Data Analysis
      • 4.2.1.2.1. Genomic Data Analysis
      • 4.2.1.2.2. Proteomic Data Analysis
      • 4.2.1.2.3. Variant Data Analysis
    • 4.2.1.3. Drug Discovery Services
    • 4.2.1.4. Differential Gene Expression Analysis
    • 4.2.1.5. Database Management Services
    • 4.2.1.6. Others
  • 4.2.2. By Application
    • 4.2.2.1. Genomics
    • 4.2.2.2. Proteomics
    • 4.2.2.3. Chemoinformatics and Drug Design
    • 4.2.2.4. Pharmacogenomics
    • 4.2.2.5. Transcriptomics
    • 4.2.2.6. Metabolomics
    • 4.2.2.7. Others
  • 4.2.3. By Specialty
    • 4.2.3.1. Medical Biotechnology
    • 4.2.3.2. Animal Biotechnology
    • 4.2.3.3. Forensic Biotechnology
    • 4.2.3.4. Plant Biotechnology
    • 4.2.3.5. Environmental Biotechnology
  • 4.2.4. By End-user
    • 4.2.4.1. Academic Institutes and Research Centers
    • 4.2.4.2. Hospitals and Clinics
    • 4.2.4.3. Pharmaceutical and Biotechnology Companies
    • 4.2.4.4. Contract Research Organizations (CROs)
    • 4.2.4.5. Others
  • 4.2.5. By Region
    • 4.2.5.1. North America
    • 4.2.5.2. Europe
    • 4.2.5.3. Asia-Pacific
    • 4.2.5.4. South America
    • 4.2.5.5. Middle East and Africa
  • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 4.3. Market Map Analysis, 2024
  • 4.3.1. By Type
  • 4.3.2. By Application
  • 4.3.3. By Specialty
  • 4.3.4. By End-user
  • 4.3.5. By Region

5. North America Bioinformatics Services Market Outlook, 2018-2032F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Type
    • 5.2.1.1. Sequencing Services
      • 5.2.1.1.1. Exome Analysis
      • 5.2.1.1.2. Transcriptome Analysis
      • 5.2.1.1.3. Metagenomic Analysis
      • 5.2.1.1.4. Other Services
    • 5.2.1.2. Data Analysis
      • 5.2.1.2.1. Genomic Data Analysis
      • 5.2.1.2.2. Proteomic Data Analysis
      • 5.2.1.2.3. Variant Data Analysis
    • 5.2.1.3. Drug Discovery Services
    • 5.2.1.4. Differential Gene Expression Analysis
    • 5.2.1.5. Database Management Services
    • 5.2.1.6. Others
  • 5.2.2. By Application
    • 5.2.2.1. Genomics
    • 5.2.2.2. Proteomics
    • 5.2.2.3. Chemoinformatics and Drug Design
    • 5.2.2.4. Pharmacogenomics
    • 5.2.2.5. Transcriptomics
    • 5.2.2.6. Metabolomics
    • 5.2.2.7. Others
  • 5.2.3. By Specialty
    • 5.2.3.1. Medical Biotechnology
    • 5.2.3.2. Animal Biotechnology
    • 5.2.3.3. Forensic Biotechnology
    • 5.2.3.4. Plant Biotechnology
    • 5.2.3.5. Environmental Biotechnology
  • 5.2.4. By End-user
    • 5.2.4.1. Academic Institutes and Research Centers
    • 5.2.4.2. Hospitals and Clinics
    • 5.2.4.3. Pharmaceutical and Biotechnology Companies
    • 5.2.4.4. Contract Research Organizations (CROs)
    • 5.2.4.5. Others
  • 5.2.5. By Country Share
    • 5.2.5.1. United States
    • 5.2.5.2. Canada
    • 5.2.5.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Bioinformatics Services Market Outlook, 2018-2032F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Type
        • 5.3.1.2.1.1. Sequencing Services
        • 5.3.1.2.1.1.1. Exome Analysis
        • 5.3.1.2.1.1.2. Transcriptome Analysis
        • 5.3.1.2.1.1.3. Metagenomic Analysis
        • 5.3.1.2.1.1.4. Other Services
        • 5.3.1.2.1.2. Data Analysis
        • 5.3.1.2.1.2.1. Genomic Data Analysis
        • 5.3.1.2.1.2.2. Proteomic Data Analysis
        • 5.3.1.2.1.2.3. Variant Data Analysis
        • 5.3.1.2.1.3. Drug Discovery Services
        • 5.3.1.2.1.4. Differential Gene Expression Analysis
        • 5.3.1.2.1.5. Database Management Services
        • 5.3.1.2.1.6. Others
      • 5.3.1.2.2. By Application
        • 5.3.1.2.2.1. Genomics
        • 5.3.1.2.2.2. Proteomics
        • 5.3.1.2.2.3. Chemoinformatics and Drug Design
        • 5.3.1.2.2.4. Pharmacogenomics
        • 5.3.1.2.2.5. Transcriptomics
        • 5.3.1.2.2.6. Metabolomics
        • 5.3.1.2.2.7. Others
      • 5.3.1.2.3. By Specialty
        • 5.3.1.2.3.1. Medical Biotechnology
        • 5.3.1.2.3.2. Animal Biotechnology
        • 5.3.1.2.3.3. Forensic Biotechnology
        • 5.3.1.2.3.4. Plant Biotechnology
        • 5.3.1.2.3.5. Environmental Biotechnology
      • 5.3.1.2.4. By End-user
        • 5.3.1.2.4.1. Academic Institutes and Research Centers
        • 5.3.1.2.4.2. Hospitals and Clinics
        • 5.3.1.2.4.3. Pharmaceutical and Biotechnology Companies
        • 5.3.1.2.4.4. Contract Research Organizations (CROs)
        • 5.3.1.2.4.5. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Bioinformatics Services Market Outlook, 2018-2032F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Poland

7. Asia-Pacific Bioinformatics Services Market Outlook, 2018-2032F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Bioinformatics Services Market Outlook, 2018-2032F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Bioinformatics Services Market Outlook, 2018-2032F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa
• 9.4. Israel

10. Demand Supply Analysis

11. Porter's Five Forces Analysis

12. PESTLE Analysis

13. Pricing Analysis

14. Market Dynamics

• 14.1. Market Drivers
• 14.2. Market Challenges

15. Market Trends and Developments

16. Regulatory Framework and Innovation

• 16.1. Developments and Innovations
• 16.2. Regulatory Approvals

17. Patent Landscape

18. Case Studies

19. Competitive Landscape

• 19.1. Competition Matrix of Top 5 Market Leaders
• 19.2. SWOT Analysis for Top 5 Players
• 19.3. Key Players Landscape for Top 10 Market Players
  • 19.3.1. Agilent Technologies, Inc.
    • 19.3.1.1. Company Details
    • 19.3.1.2. Key Management Personnel
    • 19.3.1.3. Products and Services
    • 19.3.1.4. Financials (As Reported)
    • 19.3.1.5. Key Market Focus and Geographical Presence
    • 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 19.3.2. Thermo Fisher Scientific Inc.
  • 19.3.3. CD Genomics
  • 19.3.4. PerkinElmer AES
  • 19.3.5. Fios Genomics Ltd
  • 19.3.6. QIAGEN N.V.
  • 19.3.7. Source BioScience Limited
  • 19.3.8. Biomax GmbH
  • 19.3.9. Illumina, Inc.
  • 19.3.10. BGI Group

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

20. Strategic Recommendations

21. About Us and Disclaimer